Clinical Trials › NCT06890923
RecruitingPhase 2
Nasal Foralumab in Patients With Non-Active Secondary Progressive Multiple Sclerosis
Sponsored by Tiziana Life Sciences LTD
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 55
Target enrollment
1
U.S. states
Mar 2025
Start date
Aug 2026
Expected completion
Interventions / Treatments
Foralumab TZLS-401 100 µg
Conditions studied
Non-Active Secondary Progressive Multiple Sclerosis
Where this trial is running (1 site)
Massachusetts1 site
Boston
Participating MS centers on MS Buddy (1)
Brigham Multiple Sclerosis Center
Boston, MA
Boston, MA
MS centers in Massachusetts
Compare treatment centers near a trial site by center type, providers and trials.
View Massachusetts centersMore Phase 2 trials
Browse all Phase 2 MS trialsThe app
Check out the MS Buddy app
Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.